New insider activity at CME Group ( (CME) ) has taken place on September 17, 2025.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Timothy Francis McCourt, the Senior Managing Director and Global Head of Equity & FX at CME Group, recently sold 1,133 shares of the company’s stock. This transaction was valued at $293,633, highlighting a significant movement in the executive’s stock holdings.
Spark’s Take on CME Stock
According to Spark, TipRanks’ AI Analyst, CME is a Outperform.
CME Group’s strong financial performance and positive earnings call are the most significant factors driving the score. While technical indicators suggest a bearish trend, the company’s robust profitability and attractive dividend yield provide a solid foundation for long-term growth. The favorable legal outcome further supports its market position.
To see Spark’s full report on CME stock, click here.
More about CME Group
YTD Price Performance: 13.06%
Average Trading Volume: 2,187,258
Technical Sentiment Signal: Buy
Current Market Cap: $93.28B